SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing attention amid a high-volume rally and anticipation of founder Patrick Soon-Shiongs scheduled fireside chat, where investors are looking for trial updates. Traders also connect the broader NIH cancer-vaccine push to the companys investigational vaccine work; hopes for a partnership or short squeeze remain speculative.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines volatile pullback and range-bound trading are driving discussion, with traders debating whether low-volume selling and options activity are weighing on shares or creating a buying opportunity ahead of earnings. Bullish investors point to improving growth and cash flow, while others remain concerned about dilution and the stocks weakness.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

The FDAs acceptance of Intellias lonvo-z application for priority review has focused attention on its potential to bring a one-time gene-editing treatment for hereditary angioedema toward commercialization. Bulls see the regulatory milestone and Phase 3 results as validation, while skeptics point to financing and launch risks and question why the shares have reacted modestly.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs plan to acquire low-band spectrum and expand Starlink Mobile into a wireless carrier has raised concerns about future competition, weighing on T-Mobile shares. Traders debate whether the selloff reflects a genuine long-term threat or an overreaction given SpaceXs need to build out its network and T-Mobiles existing customer base and infrastructure.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins sharp rally is driving attention, with traders pointing to the Grayscale ETF filing and renewed interest in its proof-of-human identity use case amid growing AI-agent activity; some also cite Eightcos large WLD holdings as a source of institutional interest. Optimism about further gains and a potential short squeeze is tempered by skepticism over the tokens volatility and the fact that ETF approval remains uncertain.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Record-high diesel prices and unusually wide refining margins amid global supply disruptions are driving attention to Valero, with traders citing stronger profit expectations for refiners. The bullish margin outlook is being weighed against uncertainty over Russias proposed diesel supply deal and possible U.S. export restrictions, as well as profit-taking after VLOs sharp rally.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound and repeated tests of resistance have fueled breakout talk, with bulls accumulating on dips while bears warn the move could fade. Traders also debate whether Chainlinks institutional and tokenization adoption will translate into lasting value for the LINK token.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias planned early exit from its Rockville headquarters and procedural extensions in its generic-patent litigation have fueled speculation that a sale or further settlements may be approaching, though neither is confirmed. Traders welcomed the share-price rebound but debated whether it reflects company-specific developments or broader biotech-sector strength, with some expecting the gains to fade.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention over weaker 2027 Medicare Advantage star ratings for Aetna, which traders say could reduce bonus payments and pressure future margins; the setback is being contrasted with Humanas improved ratings. Some traders are bearish on the business impact, while others view the selloff as an oversold reaction.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

A Hunterbrook short report alleging Lennars Millrose spinoff bought large numbers of completed homes has raised concerns about related-party sales and reported deliveries. Traders are weighing those allegations and weak housing demand amid high mortgage rates against Berkshire Hathaways continued buying of Lennar shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beta Bionics (BBNX) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline

Beta Bionics (BBNX) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline Beta Bionics (BBNX) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 3...

BBNX Deadline Alert: SueWallSt Reminds Beta Bionics, Inc. (BBNX) Investors of Securities Class Action Deadline on November 3, 2026

BBNX Deadline Alert: SueWallSt Reminds Beta Bionics, Inc. (BBNX) Investors of Securities Class Action Deadline on November 3, 2026 BBNX Deadline Alert: SueWallSt Reminds Beta Bionics, Inc. (BBNX) Investors of Securities Class Action Deadline on November 3, 2026PR NewswireNEW YORK, Oct. 8, 2026A...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBNX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBNX INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and...

Kirby McInerney LLP Alerts Investors Who Acquired Beta Bionics, Inc. BBNX Securities Between July 30, 2025 and February 24, 2026 of Pending Lawsuit

Kirby McInerney LLP reminds Beta Bionics, Inc. (Beta Bionics or the Company) (NASDAQ: BBNX) investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email...

BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the Firm

BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the Firm BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the FirmPR NewswireNEW YORK, Oct. 7, 2026Alert: Beta...

Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance

Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA CompliancePR NewswireSAN FRANCISCO, Oct. 7, 2026SAN FRANCISCO, Oct. 7, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX)faces a...

BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action LawsuitPR NewswireSAN FRANCISCO, Oct. 6, 2026SAN...

BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues Disclosed - Securities Fraud Class Action Filed

BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues Disclosed - Securities Fraud Class Action Filed BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues Disclosed - Securities Fraud Class Action FiledPR NewswireNEW YORK, Oct. 6...

Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX

Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNXPR NewswireNEW YORK, Oct. 5, 2026NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The...

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces...

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Beta Bionics Inc.

Beta Bionics Stock Gains After Mixed Analyst Coverage; Wolfe Bullish, Goldman Neutral

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$17.63
Prev Close	$17.43
Open	$17.47
Dividend Yield	0.00%
50-Day Moving Average	$18.63
Beta	1.51
Avg. Volume	1.52M
PE Ratio	-10.70

52-Week High	$32.71
52-Week Low	$8.80
Market Capitalization	$940.28M
EPS (Annual)	-$1.81
Price to Book	3.09
Revenue Per Employee	$237,000.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

BBNX Fundamentals